Literature DB >> 32885407

Angiosarcomas: histology, immunohistochemistry and molecular insights with implications for differential diagnosis.

Isidro Machado1,2, Francisco Giner3, Javier Lavernia4, Julia Cruz1, Víctor Traves1, Celia Requena5, Beatriz Llombart5, José Antonio López-Guerrero6,7,8, Antonio Llombart-Bosch9.   

Abstract

Angiosarcomas (AS) represent a heterogenous group of tumors with variable clinical presentation. AS share an important morphologic and immunohistochemical overlap with other sarcomas, hence the differential diagnosis is challenging, especially in poorly-differentiated tumors. Although molecular studies provide significant clues, especially in the differential diagnosis with other vascular neoplasms, a thorough hematoxylin and eosin analysis remains an essential tool in AS diagnosis. In this review, we discuss pathological and molecular insights with emphasis on implications for differential diagnosis in cutaneous, breast, soft tissue and visceral AS.

Entities:  

Year:  2020        PMID: 32885407     DOI: 10.14670/HH-18-246

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  112 in total

Review 1.  Malignant Vascular Tumors of the Liver in Adults.

Authors:  Venancio Avancini Ferreira Alves; Jordi Rimola
Journal:  Semin Liver Dis       Date:  2018-12-07       Impact factor: 6.115

Review 2.  Vascular lesions of the breast.

Authors:  Gabrielle M Baker; Stuart J Schnitt
Journal:  Semin Diagn Pathol       Date:  2017-05-30       Impact factor: 3.464

Review 3.  Malignant vascular tumors--an update.

Authors:  Cristina Antonescu
Journal:  Mod Pathol       Date:  2014-01       Impact factor: 7.842

4.  Treatment and outcome of 82 patients with angiosarcoma.

Authors:  John A Abraham; Francis J Hornicek; Adam M Kaufman; David C Harmon; Dempsey S Springfield; Kevin A Raskin; Henry J Mankin; David G Kirsch; Andrew E Rosenberg; G Petur Nielsen; Vikram Desphpande; Herman D Suit; Thomas F DeLaney; Sam S Yoon
Journal:  Ann Surg Oncol       Date:  2007-03-14       Impact factor: 5.344

5.  CD30 expression in malignant vascular tumors and its diagnostic and clinical implications: a study of 146 cases.

Authors:  Meghna Alimchandani; Zeng-Feng Wang; Markku Miettinen
Journal:  Appl Immunohistochem Mol Morphol       Date:  2014 May-Jun

Review 6.  Angiosarcoma arising in association with vascular Dacron grafts and orthopedic joint prostheses: clinicopathologic, immunohistochemical, and molecular study.

Authors:  Abbas Agaimy; Ofer Ben-Izhak; Thomas Lorey; Marcus Scharpf; Brian P Rubin
Journal:  Ann Diagn Pathol       Date:  2016-01-11       Impact factor: 2.090

7.  KDR activating mutations in human angiosarcomas are sensitive to specific kinase inhibitors.

Authors:  Cristina R Antonescu; Akihiko Yoshida; Tianhuo Guo; Ning-En Chang; Lei Zhang; Narasimhan P Agaram; Li-Xuan Qin; Murray F Brennan; Samuel Singer; Robert G Maki
Journal:  Cancer Res       Date:  2009-09-01       Impact factor: 12.701

8.  Primary mammary angiosarcomas harbor frequent mutations in KDR and PIK3CA and show evidence of distinct pathogenesis.

Authors:  Francisco Beca; Gregor Krings; Yunn-Yi Chen; Elizabeth M Hosfield; Poonam Vohra; Richard K Sibley; Megan L Troxell; Robert B West; Kimberly H Allison; Gregory R Bean
Journal:  Mod Pathol       Date:  2020-03-02       Impact factor: 7.842

9.  Association Between Programmed Death-Ligand 1 Expression and the Vascular Endothelial Growth Factor Pathway in Angiosarcoma.

Authors:  Sanjay P Bagaria; Zoran Gatalica; Todd Maney; Daniel Serie; Mansi Parasramka; Steven Attia; Murli Krishna; Richard W Joseph
Journal:  Front Oncol       Date:  2018-03-22       Impact factor: 6.244

10.  Primary and secondary breast angiosarcoma: single center report and a meta-analysis.

Authors:  Yara Abdou; Ahmed Elkhanany; Kristopher Attwood; Wenyan Ji; Kazuaki Takabe; Mateusz Opyrchal
Journal:  Breast Cancer Res Treat       Date:  2019-09-14       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.